Use Of Lamotrigine In Pregnancy Appears Not To Raise The Risk For Certain Birth Defects

HealthDay (4/6, Preidt) reports that use of the epilepsy and off-label depression medication lamotrigine “during pregnancy may not raise the risk for certain birth defects,” the findings of a study published online April 6 in Neurology suggest. After analyzing “data on more than 10 million births over 16 years, including almost 227,000 babies with birth defects,” researchers found that infants “born with cleft lip, cleft palate or clubfoot were not significantly more likely than those with other birth defects to have been born to mothers who took lamotrigine in the first trimester of pregnancy.”

Related Links:

— “Study Sees No Link Between Common Epilepsy Drug, Certain Birth Defects,” Robert Preidt, HealthDay, April 6, 2016.

Posted in In The News.